Molecule
Accelerating discovery, research & development and collaboration for novel therapeutics. With the power of blockchain and fractionalized IP.
Founders
Paul Kohlhaas, Tyler Golato, Titian Steiger
Backed By
Lunar Ventures, Inflection VC, Signature Ventures, Inventures Collective
About
Molecule is an open ecosystem for pharmaceutical and biotech IP to accelerate discovery, R&D and collaboration. Drug development has traditionally remained in silos, rendering the research-to-commercialization process extremely cumbersome, expensive and opaque.
By creating a blockchain-enabled open platform for scientists and drug developers to share IP, access capital and lower collaboration costs, Molecule seeks to upend the way traditional R&D functions, especially in highly relevant domains like virology, longevity, psychedelics and neglected diseases.